Is the use of intranasal glucocorticosteroids (inGCSs) in children safe?
Journal Title: Otolaryngologia Polska - Year 2015, Vol 69, Issue 1
Abstract
It’s been 40 years since Niels Mygind publication in British Medical Journal on intranasal application of beclomethasonedipropionate aerosol in Allergic Rhinitis. Since then the new era in treatment of allergic and non-allergic upper airway diseases has begun.This publication presents current concepts on application of intranasal glucocorticosteroids in treatment of upper airway diseases and in particular of allergic rhinitis and rhinosinusitis.The non-questionable advantage of intranasal glucocorticosteroids is their strong anti-inflammatory local action with little impact on general health responsible for few and benign side effects. Main way of action of glucocorticosteroids is connected with binding to the intracellular glucocorticosteroid receptor and its impact on nuclear cytoplasmic transcriptional factors. Glucocorticosteroids suppress gene expression of factors responsible for generating and supporting inflammatory processes, pro-inflammatory cytokines and chemokines production, adhesive molecules expression. It appears that glucocorticosteroids has also other mechanisms of action, non-involving intracellular receptors, leading to inhibiting of early and late phase of allergic reaction.At the moment there are following glucocorticosteroids registered in Poland: beclomethasone, budesonide, fluticasone propionate, fluticasone fuorate, mometasonefuorate. Special attention earns fuorates as their lateral fuorate ester chain makes this molecules highly lipophilic, easily absorbed by nasal mucous membranes epithelium and cell membranes phospholipids. This minimizes their general action and maximizes local action. According to current state of knowledge topical glucocorticosteroids are used in the following upper airway diseases with different inflammatory mechanism: allergic rhinitis, non-allergic rhinitis, particularly NARES, acute rhinosinusitis, chronic rhinosinusitis with and without nasal polyps, adenoid hypertrophy and rhinitis in bronchial asthma.
Authors and Affiliations
Anna Nowicka, Bolesław Samoliński
Keywords
Related Articles
- EP ID EP52575
- DOI -
- Views 110
- Downloads 0
Parotid gland tumors. Results of retrospective analysis of 149 patients treated at the Clinical Department of Cranio-Maxillofacial Surgery, Clinic of Otolaryngology and Oncologic Laryngology of Military Institute of Medicine in Warsaw in years 2006–2016.
Wstęp: Nowotwory mające swoją etiologię w gruczołach ślinowych występują rzadko i stanowią ok. 3–10% wszystkich guzów w obrębie głowy i szyi. Materiał i metody: W latach 2006–2016 w Klinicznym Oddziale Chirurgii Czaszkow...
Bleeding as an initial symptom of tonsillar carcinoma
The authors present the case of the patient suffering from recurrent bleeding from the palatine tonsil. A visual and tactile examination did not reveal any alteration to the tonsil. Following three recurrent bleeding epi...
Obiektywizacja stopnia nasilenia zmian w obrzękach Reinkego
According to the severity, Reinke's edema (RE) of the vocal folds can be divided into three stages as classifi ed by Yoneka wa. We evaluated open and closed quotients of vocal folds vibratory cycle s using Videostrobokym...
Neoplasms of paranasal sinuses in material of ENT Department MSS Hospital in Warsaw between 2006–2007
Tumors of paranasal sinuses present a small percent of tumors detected in the region of head and neck 3–4% and they present a fraction of a percent of tumors in general /0,16%/. Material. In the years 2004 and 2005, the...
Co może uzyskać otolaryngolog, stosując sztuczne sieci neuronowe?